Patient EngagementNCT04410380
Patient Portal Use by Parents of Spanish-Speaking Children
A study testing Electronic tablet provision with teaching in people with Patient Engagement, run by University of North Carolina, Chapel Hill at 1 site in United States.
Trial summary
The purpose of this study is to determine whether patient portal access is feasible and useful for Spanish-speaking parents. Participants will be given an electronic tablet and will be taught how to access their child's medical record and other electronic health resources using the tablet. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Patient Engagement
- What is being tested?
- Electronic tablet provision with teaching
- Type of treatment
- Pill or oral medicine, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 25 participants
- Where
- 1 siteUnited States
- Study dates
- 2 Aug 2020to 30 Dec 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Be parent/legal guardians of children receiving care in UNC's Children's Clinics
- Have Spanish as preferred language of individual identifying as primary caregiver
- Have never activated MyChart (patient portal)
- Have internet service at home OR ability to easily access internet service
- Have at least one child under age 13
Who cannot join
- Medically unstable at time of recruitment
Trial locations and contacts
1 site in 1 country.
About this study
The purpose of this study is to determine whether patient portal access is feasible and useful for Spanish-speaking parents.
Participants will be given an electronic tablet and will be taught how to access their child's medical record and other electronic health resources using the tablet.
- Conditions
- Patient Engagement
- Being tested
- Electronic tablet provision with teaching
- Medical subject headings
- Patient Participation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Electronic tablet provision with teachingBehavioural
Spanish-speaking parents are provided with an electronic tablet and taught how to use it to access health information for their children.
| Study group | Role | What they receive |
|---|---|---|
| Electronic tablet | Experimental | Spanish-speaking parents receive electronic tablet and teaching about use Receives: Behavioral: Electronic tablet provision with teaching |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percent of Parents Activating Patient Portal
To determine patient portal use.
Measured: 6 months
Secondary outcomes (1)
Change in Parent Attitudes Toward Health Information Technology
Parent attitudes and perceptions will be assessed by survey at enrollment and 1 month after intervention. Scale name: Reasons to use more health information technology. Range 3-12. Directionality: Higher scores indicate more favorable attitudes toward health information technology
Measured: Baseline, 1 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Jun 2020
- Study start2 Aug 2020
- Primary completion30 Dec 2022
- Study completion30 Dec 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Patient EngagementStudies of the same condition, open and under way.
- More trials run by University of North Carolina, Chapel HillThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 25 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of North Carolina, Chapel Hill
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Kori Flower, MD, MS, MPH, Principal investigator, University of North Carolina, Chapel Hill
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04410380
- Sponsor's protocol ID
- 19-1545
- Status last verified
- Mar 2022
- First submitted
- 27 May 2020
- Last updated
- 14 Mar 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Mar 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Patient Portal Use by Parents of Spanish-Speaking Children
- ClinicalTrials.gov ID
- NCT04410380
- Acronym / sponsor ID
- 19-1545
- Conditions
- Patient Engagement
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 25 participants (actual)
- Lead sponsor
- University of North Carolina, Chapel HillUniversity, hospital or other
- Study start
- 2 Aug 2020 (actual)
- Primary completion
- 30 Dec 2022 (actual)
- Study completion
- 30 Dec 2022 (actual)
- First posted
- 1 Jun 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine whether patient portal access is feasible and useful for Spanish-speaking parents.
Participants will be given an electronic tablet and will be taught how to access their child's medical record and other electronic health resources using the tablet.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Electronic tablet | Experimental | Behavioral: Electronic tablet provision with teachingSpanish-speaking parents receive electronic tablet and teaching about use |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (5 listed)
- Be parent/legal guardians of children receiving care in UNC's Children's Clinics
- Have Spanish as preferred language of individual identifying as primary caregiver
- Have never activated MyChart (patient portal)
- Have internet service at home OR ability to easily access internet service
- Have at least one child under age 13
Key exclusion criteria (1 listed)
- Medically unstable at time of recruitment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Electronic tablet provision with teachingSpanish-speaking parents are provided with an electronic tablet and taught how to use it to access health information for their children. | Behavioural | Electronic tablet |
Primary outcome
Percent of Parents Activating Patient Portal
Time frame: 6 months
To determine patient portal use.
1 secondary outcome
Change in Parent Attitudes Toward Health Information Technology
Time frame: Baseline, 1 month
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Mar 2023.
- Individual participant dataSharing planned: No
Related trials for Patient Engagement
RecruitingPhase 2
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
Multiple Myeloma
RecruitingObservational study
The Decision To Enroll In Therapeutic Clinical Trials In A Pediatric Cancer Clinical Network
Knowledge, Attitudes, Practice
Not yet recruiting
A Novel Miniature Equine-Assisted Diabetes Education Program for Youth: Evaluating the Diabetes Equine Empowerment Program (DEEP).
Diabetes (Insulin-requiring, Type 1 or Type 2), Pediatric Diabetes
Recruiting
ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction
Breast Cancer, Cancer of the Breast
Not yet recruitingObservational study
Implementing Dynamic Consent for Rare Disease Patients
Rare Disorders
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kori Flower, MD, MS, MPH principal investigator
University of North Carolina, Chapel Hill
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Electronic tablet provision with teaching in people with Patient Engagement, run by University of North Carolina, Chapel Hill at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percent of Parents Activating Patient Portal (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Mar 2023.